Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review

Date: June 6, 2017
Pages: 49
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A1F60DE6B6FEN
Leaflet:

Download PDF Leaflet

Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review
Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Almirall SA (Almirall) is a specialty pharmaceutical company which researches, develops, manufactures and commercializes proprietary medicines and licensed products. The company’s key area of focus is dermatology covering psoriasis, eczema, acne and other skin infections. It also develops products in the autoimmune diseases including rheumatoid arthritis and multiple sclerosis; and gastrointestinal diseases including irritable bowel syndrome with constipation. Some of its major products include Actikerall, Balneum; Solaraze; Decoderm and Sativex among others. The company also works together with small and medium sized companies for the development of drugs and their marketing. It operates through affiliates in Europe and Central America and has R&D centers in Spain and Germany. Almirall is headquartered in Barcelona, Spain.

Almirall SA Key Recent Developments

Dec 12,2016: Almirall and Nuevolution enter into global strategic collaboration
Nov 07,2016: Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in US
Oct 18,2016: Almirall announces a restructuring plan in Spain
Jul 26,2016: Almirall H1 results 2016: Growth in Total Revenues and Net Sales driven by Dermatology
May 09,2016: Almirall's Q1 results 2016: on track to achieve yearly guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Almirall SA - Key Facts
Almirall SA - Key Employees
Almirall SA - Key Employee Biographies
Almirall SA - Major Products and Services
Almirall SA - History
Almirall SA - Company Statement
Almirall SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Almirall SA - Business Description
Almirall SA - Corporate Strategy
Almirall SA - SWOT Analysis
SWOT Analysis - Overview
Almirall SA - Strengths
Almirall SA - Weaknesses
Almirall SA - Opportunities
Almirall SA - Threats
Almirall SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Almirall SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Almirall SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 12, 2016: Almirall and Nuevolution enter into global strategic collaboration
Nov 07, 2016: Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in US
Jul 26, 2016: Almirall H1 results 2016: Growth in Total Revenues and Net Sales driven by Dermatology
May 09, 2016: Almirall's Q1 results 2016: on track to achieve yearly guidance
Feb 24, 2016: Almirall reduces its accident rate by 69% in Spain in 2015
Feb 22, 2016: Almirall Full-Year 2015 results: Normalized Net Income growth of 90%
Feb 22, 2016: Almirall Full-Year 2015 results: Normalized Net Income growth of 90%

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Almirall SA, Key Facts
Almirall SA, Key Employees
Almirall SA, Key Employee Biographies
Almirall SA, Major Products and Services
Almirall SA, History
Almirall SA, Subsidiaries
Almirall SA, Key Competitors
Almirall SA, Ratios based on current share price
Almirall SA, Annual Ratios
Almirall SA, Annual Ratios (Cont.1)
Almirall SA, Annual Ratios (Cont.2)
Almirall SA, Interim Ratios
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Almirall SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Almirall SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Almirall SA, Performance Chart (2012 - 2016)
Almirall SA, Ratio Charts
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Almirall SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sucampo Pharmaceuticals Inc
Laboratorios Del Dr Esteve SA
Laboratorio CIFGA SA
GlaxoSmithKline Plc
Faes Farma SA
Biosearch Life
Baxter International Inc
Aquinox Pharmaceuticals Inc
ALK-Abello A/S
Skip to top


Ask Your Question

Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: